Carcinoid syndrome symposium on treatment modalities for gastrointestinal carcinoid tumours: symposium summary.
OBJECTIVE
To develop a collaborative approach for the treatment of gastrointestinal carcinoid tumours and carcinoid syndrome.


METHODS
Leaders in the medical, endocrine, radiologic and surgical treatment of carcinoid disease were selected to present papers at the Carcinoid Syndrome Symposium on Treatment Modalities for Gastrointestinal Carcinoid Tumours and participate in the workshop that followed.


METHODS
A multidisciplinary symposium with experts in the field of carcinoid syndrome was organized at the University of Calgary. Data presented, participation of the attendees and a review of the literature were used in the workshop to develop a collaborative approach to the management of carcinoid tumours.


RESULTS
Carcinoid tumours are rare and few centres have large experiences in their treatment. Before the development of this collaboration, patients with carcinoid tumours received a unidisciplinary approach depending on referral patterns. The development of a multidisciplinary neuroendocrine clinic helped to unify the approach to these patients, yet a consensus on the treatment of carcinoid tumours was lacking. The expertise at the symposium allowed for consensus and the development of treatment algorithms, including biochemical screening, radiographic localization and surgical intervention, for gastrointestinal carcinoid tumours. The role of medical and hormonal therapy after cytoreducion is presented.


CONCLUSIONS
Patients with carcinoid tumours require a multidisciplinary approach to their care.
Pasieka
J L
JL
Department of Surgery, University of Calgary, Alta. Janice.Pasieka@CRHA-Health.ab.ca
McKinnon
J G
JG
Kinnear
S
S
Yelle
C A
CA
Numerow
L
L
Paterson
A
A
Rorstad
O
O
DiFrancesco
L M
LM
McEwan
A
A
Skogseid
B
B
D000465:Algorithms; D001063:Appendiceal Neoplasms / Q000000981:diagnostic imaging; D002276:Carcinoid Tumor / Q000000981:diagnostic imaging / Q000556:secondary / Q000628:therapy*; D005770:Gastrointestinal Neoplasms / Q000000981:diagnostic imaging / Q000556:secondary / Q000628:therapy*; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine; D008113:Liver Neoplasms / Q000556:secondary; D013577:Syndrome; D014057:Tomography, X-Ray Computed
D006897:Hydroxyindoleacetic Acid